ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells

Journal of Cell Biology

Volumn 158, Issue 2, 2002, Pages 345-355

  Ryten, Mina ^a   Dunn, Philip M ^a   Neary, Joseph T ^b   Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; Differentiation; P2X5; Satellite cells; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; MUSCLE PROTEIN; PURINE P2 RECEPTOR; PURINE P2X5 RECEPTOR;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; DRUG EFFECT; MUSCLE CONTRACTION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 0037157816     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.200202025     Document Type: Article

References (59)

1. Abbracchio, M.P., and G. Burnstock. 1998. Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 78:113-145.
2. Adi, S., B. Bin-Abbas, N.Y. Wu, and S.M. Rosenthal. 2002. Early stimulation and late inhibition of extracellular signal-regulated kinase1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology. 143:511-516.
3. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
4. Bennett, A.M., and N.K. Tonks. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science. 278:1288-1291.
5. Black, B.L., and E.N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
6. Burnstock, G. 1997. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology. 36:1127-1139.
7. Campbell, J.S., M.P. Wenderoth, S.D. Hauschka, and E.G. Krebs. 1995. Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells. Proc. Natl. Acad. Sci. USA. 92:870-874.
8. Choi, R.C., M.L. Man, K.K. Ling, N.Y. Ip, J. Simon, E.A. Barnard, and K.W. Tsim. 2001. Expression of the P2Y1 nucleotide receptor in chick muscle: its functional role in the regulation of acetylcholinesterase and acetylcholine receptor. J. Neurosci. 21:9224-9234.
9. Chun, Y.K., J. Kim, S. Kwon, S.H. Choi, F. Hong, K. Moon, J.M. Kim, S.L. Choi, B.S. Kim, J. Ha, and S.S. Kim. 2000. Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 276:502-507.
10. Conejo, R., and M. Lorenzo. 2001. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. J. Cell. Physiol. 187:96-108.
11. Coutinho Silva, R., P.M. Persechini, R.D. Bisaggio, J.L. Perfettini, A.C. Neto, J.M. Kanellopoulos, I. Motta Ly, A. Dautry Varsat, and D.M. Ojcius. 1999. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am. J. Physiol. 276: C1139-C1147.
12. Cross, J.V., J.C. Deak, E.A. Rich, Y. Qian, M. Lewis, L.A. Parrott, K. Mochida, D. Gustafson, S. Vande Pol, and D.J. Templeton. 1999. Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J. Biol. Chem. 274:31150-31154.
13. Cuenda, A., J. Rouse, Y.N. Doza, R. Meier, P. Cohen, T.F. Gallagher, P.R. Young, and J.C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229-233.
14. Cunha, R.A., and A.M. Sebastiao. 1993. Adenosine and adenine nucleotides are independently released from both the nerve terminals and the muscle fibres upon electrical stimulation of the innervated skeletal muscle of the frog. Pflugers Arch. 424:503-510.
15. Daniels, M.P., B.T. Lowe, S. Shah, J. Ma, S.J. Samuelsson, B. Lugo, T. Parakh, and C.S. Uhm. 2000. Rodent nerve-muscle cell culture system for studies of neuromuscular junction development: refinements and applications. Microsc. Res. Tech. 49:26-37.
16. Favata, M.F., K.Y. Horiuchi, E.J. Manos, A.J. Daulerio, D.A. Stradley, W.S. Feeser, D.E. Van Dyk, W.J. Pitts, R.A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623-18632.
17. Ferrari, D., M. Los, M.K. Bauer, P. Vandenabeele, S. Wesselborg, and K. Schulze-Osthoff. 1999. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447:71-75.
18. Gröschel-Stewart, U., M. Bardini, T. Robson, and G. Burnstock. 1999. Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res. 296:599-605.
19. Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 364:501-506.
20. Hawke, T.J., and D.J. Garry. 2001. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91:534-551.
21. Hellsten, Y., D. Maclean, G. Radegran, B. Saltin, and J. Bangsbo. 1998. Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation. 98:6-8.
22. Humphreys, B.D., J. Rice, S.B. Kertesy, and G.R. Dubyak. 2000. Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275:26792-26798.
23. Jones, N.C., Y.V. Fedorov, R.S. Rosenthal, and B.B. Olwin. 2001. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol. 186:104-115.
24. 2 receptor. Br. J. Pharmacol. 121:1445-1453.
25. Kim, M., L.H. Jiang, H.L. Wilson, R.A. North, and A. Surprenant. 2001. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20:6347-6358.
26. Kolb, H.A., and M.J. Wakelam. 1983. Transmitter-like action of ATP on patched membranes of cultured myoblasts and myotubes. Nature. 303:621-623.
27. Krause, D., A. Lyons, C. Fennelly, and R. O’Connor. 2001. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol. J. Biol. Chem. 276: 19244-19252.
28. Lambrecht, G. 2000. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch. Pharmacol. 362:340-350.
29. Lassar, A.B., S.X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
30. Lee, J.C., J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty, M.J. Blumenthal, J.R. Heys, and S.W. Landvatter. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:739-746.
31. Meyer, M.P., J.D. Clarke, K. Patel, A. Townsend-Nicholson, and G. Burnstock. 1999a. Selective expression of purinoceptor cP2Y1 suggests a role for nucleotide signalling in development of the chick embryo. Dev. Dyn. 214:152-158.
32. Meyer, M.P., U. Groschel-Stewart, T. Robson, and G. Burnstock. 1999b. Expression of two ATP-gated ion channels, P2X5 and P2X6, in developing chick skeletal muscle. Dev. Dyn. 216:442-449.
33. Molkentin, J.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1125-1136.
34. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, I. Nonaka, and Y. Nabeshima. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:532-535.
35. Neary, J.T., M.P. Rathbone, F. Cattabeni, M.P. Abbracchio, and G. Burnstock. 1996. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19:13-18.
36. Ogilvie, M., X. Yu, V. Nicolas-Metral, S.M. Pulido, C. Liu, U.T. Ruegg, and C.T. Noguchi. 2000. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J. Biol. Chem. 275:39754-39761.
37. Panenka, W., H. Jijon, L.M. Herx, J.N. Armstrong, D. Feighan, T. Wei, V.W. Yong, R.M. Ransohoff, and BA. MacVicar. 2001. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21:7135-7142.
38. Parr, C.E., D.M. Sullivan, A.M. Paradiso, E.R. Lazarowski, L.H. Burch, J.C. Olsen, L. Erb, G.A. Weisman, R.C. Boucher, and J.T. Turner. 1994. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. USA. 91:3275-3279.
39. Perry, R.L., and M.A. Rudnicki. 2000. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 5: D750-D767.
40. Peterson, G.L. 1983. Determination of total protein. Methods Enzymol. 91:95-119.
41. Ralevic, V., and G. Burnstock. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:413-492.
42. Redman, R.S., and E.M. Silinsky. 1994. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings. J. Physiol. 477:117-127.
43. Ruppelt, A., W. Ma, K. Borchardt, S.D. Silberberg, and F. Soto. 2001. Genomic structure, developmental distribution and functional properties of the chicken P2X(5) receptor. J. Neurochem. 77:1256-1265.
44. Ryten, M., A. Hoebertz, and G. Burnstock. 2001. Sequential expression of three receptor subtypes for extracellular ATP in developing rat skeletal muscle. Dev. Dyn. 221:331-341.
45. Schachter, J.B., Q. Li, J.L. Boyer, R.A. Nicholas, and T.K. Harden. 1996. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol. 118:167-173.
46. Schachter, J.B., J.L. Boyer, Q. Li, R.A. Nicholas, and T.K. Harden. 1997. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C. Br. J. Pharmacol. 122:1021-1024.
47. Schulze-Lohoff, E., C. Hugo, S. Rost, S. Arnold, A. Gruber, B. Brune, and R.B. Sterzel. 1998. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am J Physiol. 275: F962-F971.
48. Seale, P., and M.A. Rudnicki. 2000. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 218:115-124.
49. Sheng, M., and D.T. Pak. 2000. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu. Rev. Physiol. 62:755-778.
50. Shibuya, I., K. Tanaka, Y. Hattori, Y. Uezono, N. Harayama, J. Noguchi, Y. Ueta, F. Izumi, and H. Yamashita. 1999. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J. Physiol. 514: 351-367.
51. Silinsky, E.M., and R.S. Redman. 1996. Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. J. Physiol. 492:815-822.
52. Smith, D.O. 1991. Sources of adenosine released during neuromuscular transmission in the rat. J. Physiol. 432:343-354.
53. Torres, G.E., T.M. Egan, and M.M. Voigt. 1999. Identification of a domain involved in ATP-gated ionotropic receptor subunit assembly. J. Biol. Chem. 274:22359-22365.
54. Walsh, K., and H. Perlman. 1997. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7:597-602.
55. Weyman, C.M., and A. Wolfman. 1998. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology. 139:1794-1800.
56. Wong, C.C., W.H. Poon, T.Y. Tsim, E.Y. Wong, and M.S. Leung. 2000. Gene expressions during the development and sexual differentiation of the olfactory bulb in rats. Brain Res. Dev. Brain Res. 119:187-194.
57. Wu, Z., P.J. Woodring, K.S. Bhakta, K. Tamura, F. Wen, J.R. Feramisco, M. Karin, J.Y. Wang, and P.L. Puri. 2000. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20:3951-3964.
58. Zetser, A., E. Gredinger, and E. Bengal. 1999. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274:5193-5200.
59. Zhong, Y., P.M. Dunn, Z. Xiang, X. Bo, and G. Burnstock. 1998. Pharmacological and molecular characterization of P2X receptors in rat pelvic ganglion neurons. Br. J. Pharmacol. 125:771-781.